The truth about the IMSS workers in Coahuila who presented adverse reactions to the COVID vaccine

A healthcare worker prepares a syringe to administer the Pfizer and BioNTech coronavirus disease (COVID-19) vaccine at a nursing home in Burgbernheim, Germany.  December 28, 2020. REUTERS / Hannibal Hanschke
A healthcare worker prepares a syringe to administer the Pfizer and BioNTech coronavirus disease (COVID-19) vaccine at a nursing home in Burgbernheim, Germany. December 28, 2020. REUTERS / Hannibal Hanschke

State authorities of the Mexican Institute of Social Security (IMSS) in the state of Coahuila reported on two people who had mild allergic reactions after receiving the COVID-19 vaccine. In addition, they ruled out that the effects of immunization, in both cases, had serious outcomes. On the contrary, they claim, received timely care and are in good health.

Given the rumors that claimed that one of the workers had to be intubated and another would have developed facial paralysis after receiving the first dose of the scheme created by Pfizer and BioNTech, the Coahuila Representation Office of the IMSS issued an information card to clarify the development of the cases and deny these versions.

The first of the events occurred on December 30, 2020. A specialist from the General Hospital of Zone No. 1 who underwent the inoculation presented mild allergic reactions in the following hour. According to the authorities, after spending an hour under observation, he was able to return to his home. So far, his state of health has not presented any other disorder.

The vaccination campaign for health personnel in Coahuila began on December 28, 2020 (Photo: SEDENA)
The vaccination campaign for health personnel in Coahuila began on December 28, 2020 (Photo: SEDENA)

The second case was presented with a worker from the General Hospital of Zone No. 7 of Monclova. Unlike the first, it was necessary to transfer the patient to the High Specialty Medical Unit (UMAE) of Nuevo León for safety reasons. Despite this, it was reported that his health status is good and his referral to the hospital unit was carried out according to the follow-up protocol and third-level care.

In that way They are the only two incidents in the medical personnel who have received the first dose of the scheme in the state of Coahuila and they have been classified as mild reactions. Until December 31, the regional authorities have reported the application of 1,609 doses health workers in the entity and, they assured, will continue with the campaign until they are able to apply more than 5,000 doses destined for Social Security in the region.

Despite the cases, the Representative Office called “not to mistrust biologicals and to remember that in medical history vaccines have represented salvation for multiple diseases”.

Due to its special conditions of conservation and application, the vaccine created by Pfizer and BioNTech will be applied to health personnel dedicated to the care of patients diagnosed with COVID-19 (Photo: SEDENA)
Due to its special conditions of conservation and application, the vaccine created by Pfizer and BioNTech will be applied to health personnel dedicated to the care of patients diagnosed with COVID-19 (Photo: SEDENA)

The cases of workers in Coahuila with allergic reactions are added to the 23 reported by Dr. Manuel Cervantes Ocampo, coordinator of comprehensive health care at the first level, until December 30. According to figures shown at a virtual press conference, sOnly one case has been considered serious and required the application of an antihistamine to stop the allergic reaction in the worker’s body.

Similarly, Cervantes Ocampo stated that these are expected cases because, like any medicine, lhe vaccine against the SARS-CoV-2 virus is likely to cause adverse reactions and side effects in less than 1% of the population. In this sense, the Director of Medical Benefits of the IMSS, Victor Hugo Borja Aburto, stressed the need to consider that it is a new vaccine.

Also “Some cases may present these events but it is less than 1%. Of those that we have vaccinated and observed are mild, but it is less than 1%, it is not a cause for alarm. ”, He declared.

With the recent authorization for the emergency implementation of the antidote created by the laboratories Pfizer and BioNTech, the Food and Drug Administration of the United States (FDA, for its acronym in English) issued some recommendations before receiving it. Among them stands out Inform medical staff of a possible allergy in order to prevent complications after inoculation.

MORE ABOUT THE SUBJECT

IMSS worker presented severe reactions after receiving vaccine against COVID-19: “It is an expected event”

Coahuila began the first stage of vaccination against COVID-19

Directors, the family of a doctor and an ophthalmologist: influence and irregularities in the COVID-19 vaccination in Mexico

Leave a Comment